Last reviewed · How we verify
NCT01311297
Clinical Monitoring of Endothelial Dysfunction for Pregnant Women and in the Perioperative Course
trial in Endothelial Dysfunction in 47 participants. Terminated before completion.
29 September 2012
Quick facts
| Lead sponsor | Claudia Spies |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 47 |
| Start date | 29 March 2011 |
| Primary completion | 29 September 2012 |
| Estimated completion | 29 September 2012 |
| Sites | 1 location across Germany |
Conditions studied
- Endothelial Dysfunction — all drugs for Endothelial Dysfunction →
Sponsor
Claudia Spies — full company profile →
Who can join
18 and older, female only, with Endothelial Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A single- center prospective observational study. This study evaluates different aspects of endothelial function. It investigates the endothelial leakage with the venous occlusion plethysmography and the flow-mediated vasodilatation by ischaemia reperfusion testing.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Perioperative micro-arterial function and extravasation in cytoreductive ovarian cancer surgery: an observational study.
Feldheiser A, Dathe JJ, Heinig S, Pietzner K, et al · · 2026 · cited 1× · PMID 41580514 · DOI 10.1186/s40635-025-00839-4 -
Comparison of bedside assessed arm and leg fluid filtration determined by venous congestion plethysmography in perioperative cancer patients: An observational study investigating agreement.
Hunsicker O, Heinig S, Dathe JJ, Krannich A, et al · · 2017 · cited 1× · PMID 28248863 · DOI 10.1097/md.0000000000006066
Verify or expand the search:
- PubMed search for NCT01311297
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Endothelial Dysfunction
Currently open trials in the same condition.
- NCT07487363 — TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD · Phase 1, PHASE2 · recruiting
- NCT07422974 — Perioperative Outcomes After Neoadjuvant Therapy in Colorectal Cancer · recruiting
- NCT06419959 — NightWare and Cardiovascular Health in Veterans With PTSD · NA · recruiting
- NCT07227727 — Endothelial Dysfunction After SCI · recruiting
- NCT07227740 — Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury · recruiting
Other Claudia Spies trials
Trials by the same sponsor.
- NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
- NCT04175236 — Analysis of a Short Assessment of Post Intensive Care Syndrome (PICS) · completed
- NCT02022592 — Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care · Phase 4 · completed
- NCT01974011 — DPNB vs. Modified DPNB With Ventromedial Infiltration (DPNB According to Dalens' Technique) · NA · completed
- NCT01694901 — Optimization of the Anesthetic Regimen Using the SmartPilot® System and Influence on Different Outcome Parameters - a Pi · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01311297 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Claudia Spies
- Last refreshed: 25 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01311297.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing